catalog number :
MBS3239548
products type :
Blocking Peptide
products full name :
Cnr1 Peptide - C-terminal region
products short name :
[Cnr1]
other names :
[cannabinoid receptor 1; Cannabinoid receptor 1; cannabinoid receptor 1; cannabinoid receptor 1 (brain); Brain-type cannabinoid receptor]
products gene name :
[Cnr1]
products gene name syn :
[CB1; CB-R; CB1R]
other gene names :
[Cnr1; Cnr1; CB1; CB-R; CB1A; CB1B; CB1R; CB-R; CB1]
uniprot entry name :
CNR1_MOUSE
reactivity :
Mouse, Human
form :
Lyophilized powder
storage stability :
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
tested application :
Western Blot (WB)
other info1 :
Quality control: The peptide is characterized by mass spectroscopy. Reconstitution: Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS.
DNSMGDSDCLHKHANNTASMHRAAESCIKSTVKIAKVTM
SVSTDTSAEAL.
Protein Size (# AA): 473 amino acids. Peptide Sequence: Synthetic peptide located within the following region:
products categories :
Peptide
products description :
This is a synthetic peptide designed for use in combination with anti-Cnr1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
ncbi gb acc num :
NM_007726
ncbi pathways :
Class A/1 (Rhodopsin-like Receptors) Pathway (1324706); G Alpha (i) Signalling Events Pathway (1324737); GPCR Downstream Signaling Pathway (1324735); GPCR Ligand Binding Pathway (1324705); GPCRs, Class A Rhodopsin-like Pathway (198308); GPCRs, Other Pathway (198282); Neuroactive Ligand-receptor Interaction Pathway (83250); Neuroactive Ligand-receptor Interaction Pathway (462); Non-odorant GPCRs Pathway (198395); Rap1 Signaling Pathway (869018)